Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Kymera Therapeutics, Inc. - Common Stock (NQ:KYMR)

117.28 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	117.28
Bid (Size)	46.92 (200)
Ask (Size)	140.30 (100)
Prev. Close	117.28
Today's Range	117.28 - 117.28
52wk Range	40.10 - 130.05
Shares Outstanding	55,307,775
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kymera Therapeutics (KYMR) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

Enrollment completed six months early; $1.5B cash runway into 2029.

Via The Motley Fool

Kymera Therapeutics Q2 Earnings Call Highlights ↗

August 05, 2026

Kymera Therapeutics (NASDAQ:KYMR) said it completed enrollment in its Phase 2b atopic dermatitis trial of KT-621 about six months ahead of schedule, positioning the company to report top-line data by...

Via MarketBeat

Performance

YTD	+61.2%	+61.2%
1 Month	+12.3%	+12.3%
3 Month	+57.2%	+57.2%
6 Month	+40.4%	+40.4%
1 Year	+170.9%	+170.9%

More News

Kymera's CEO Sold $6 Million in Stock After a 170% Run ↗

July 12, 2026

Via The Motley Fool

Kymera Therapeutics (NASDAQ:KYMR) Soars on Q1 2026 Revenue and EPS Beat ↗

April 30, 2026

Via Chartmill

Kymera Therapeutics Inc (NASDAQ:KYMR) Stock Falls 6.6% After Q4 2025 Earnings Miss and Extended Clinical Timelines ↗

February 26, 2026

Via Chartmill

Why Kymera Therapeutics Stock Popped This Week ↗

June 26, 2026

Via The Motley Fool

These stocks are gapping in today's session ↗

June 25, 2026

Via Chartmill

Kymera Therapeutics Stays on Track With KT-621 Trials, Teases IRF5 Data ↗

May 26, 2026

Via MarketBeat

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗

May 17, 2026

Via The Motley Fool

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗

May 17, 2026

Via The Motley Fool

Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗

May 17, 2026

Via The Motley Fool

What to Know About This Fund’s $50 Million Exit From Ascendis Pharma ↗

May 14, 2026

Via The Motley Fool

This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO ↗

May 14, 2026

Via The Motley Fool

Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700% ↗

May 14, 2026

Via The Motley Fool

Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗

March 19, 2026

Via The Motley Fool

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗

March 09, 2026

Via The Motley Fool

Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗

March 06, 2026

Via The Motley Fool

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗

March 05, 2026

Via The Motley Fool

Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗

March 04, 2026

Via The Motley Fool

Kymera (KYMR) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position ↗

February 25, 2026

Via The Motley Fool

Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ↗

February 25, 2026

Via The Motley Fool

Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗

February 25, 2026

Via The Motley Fool

Kymera Stock Up 130% as $135 Million Buy Boosts Immunology Bet ↗

February 23, 2026

Via The Motley Fool

Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗

February 17, 2026

Via The Motley Fool

Frequently Asked Questions

Is Kymera Therapeutics, Inc. - Common Stock publicly traded?

Yes, Kymera Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Kymera Therapeutics, Inc. - Common Stock trade on?

Kymera Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Kymera Therapeutics, Inc. - Common Stock?

The ticker symbol for Kymera Therapeutics, Inc. - Common Stock is KYMR on the Nasdaq Stock Market

What is the current price of Kymera Therapeutics, Inc. - Common Stock?

The current price of Kymera Therapeutics, Inc. - Common Stock is 117.28

When was Kymera Therapeutics, Inc. - Common Stock last traded?

The last trade of Kymera Therapeutics, Inc. - Common Stock was at 09/03/26 04:00 PM ET

What is the market capitalization of Kymera Therapeutics, Inc. - Common Stock?

The market capitalization of Kymera Therapeutics, Inc. - Common Stock is 6.49B

How many shares of Kymera Therapeutics, Inc. - Common Stock are outstanding?

Kymera Therapeutics, Inc. - Common Stock has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.